Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of New Risk Genes and Potential Drugs for Rheumatoid Arthritis from Multiomics Data.

Computational and mathematical methods in medicine - 1 Jan 2022

Birga Anteneh M, Ren Liping, Luo Huaichao, Zhang Yang, Huang Jian

Abstract excerpt

Rheumatoid arthritis (RA) is an autoimmune and inflammatory disease for which there is a lack of therapeutic options. Genome-wide association studies (GWASs) have identified over 100 genetic loci associated with RA susceptibility; however, the most causal risk genes (RGs) associated with, and molecular mechanism underlying, RA remain unknown. In this study, we collected 95 RA-associated loci from multiple GWASs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Arthritis, Rheumatoid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoimmunity

Share to Bayes Theorem

Share to Computational Biology

Share to Drug Development

Share to Drug Repositioning

Share to Gene Regulatory Networks

Source

Open in PubMed Open full text

Identifiers

PMID: 35140805
DOI: 10.1155/2022/6783659
PMCID: PMC8820924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of New Risk Genes and Potential Drugs for Rheumatoid Arthritis from Multiomics Data.PMID 35140805Read ↗

Identifying therapeutic targets for rheumatoid arthritis by genomics-driven integrative approachesSemantic proximity Read ↗

The Identification of Novel Therapeutic Biomarkers in Rheumatoid Arthritis: A Combined Bioinformatics and Integrated Multi-Omics ApproachSemantic proximity Read ↗

Genetics of rheumatoid arthritis contributes to biology and drug discovery.Semantic proximity Read ↗

From the era of genome analysis to the era of genomic drug discovery: a pioneering example of rheumatoid arthritis.Semantic proximity Read ↗

Update on the genetic architecture of rheumatoid arthritis.Semantic proximity Read ↗

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.Semantic proximity Read ↗

Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci.Semantic proximity Read ↗

Integrative analyses for functional mechanisms underlying associations for rheumatoid arthritis.Semantic proximity Read ↗

A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.Semantic proximity Read ↗

Integrative analysis highlighted susceptibility genes for rheumatoid arthritis.Semantic proximity Read ↗

The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatmentSemantic proximity Read ↗

Integrative Multiomics Network Analysis of Genetic Risk Factors to Infer Biomarkers and Therapeutic Targets for Rheumatoid ArthritisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.